What SVAS Biosana does

SVAS Biosana S.p.A. is an Italian medical device manufacturer and distributor founded in 1972 and headquartered in the Naples area, with administrative offices in Somma Vesuviana and its legal seat in San Giuseppe Vesuviano. The company designs, manufactures, and distributes a diversified portfolio of medical devices organized into five sub-brands: FARMEX (incontinence aids, cotton, personal care), SVAS (peritoneal dialysis products, Closed System Transfer Device for hazardous drug transfer, surgical instrument kits), MEDICAL (custom procedure packs, drapes, advanced wound dressings, gel-based medical devices), MARK MEDICAL (orthopedic prostheses, stents, angiographic guides, heart valves, contrast agents and injectors), and BORMIA (medical devices for cardiac and vascular surgery, anesthesiology, intensive care, endovascular procedures, and neuroradiology). Operations span three Italian production sites, with a workforce of approximately 400 employees supporting direct B2B sales to hospitals, clinics, and healthcare providers across Italy and through eight corporate sites abroad, including recently acquired Serbian distributors.

The company operates proprietary digital infrastructure supporting its distribution model: the SVAS myDDT mobile application manages courier deliveries (borderò, digital DDT signatures, offline operation with sync), while the patient-facing SVAS myCare app enables healthcare supply tracking, prescription authorization viewing, and delivery monitoring, both integrated with the mySAD Web backend via REST APIs. SVAS holds a broad certification stack including ISO 9001, ISO 13485, ISO 45001, ISO 27001, ISO 14001, ISO 37001, ISO 50001, UNI PDR 125:2022 (gender equality), and GDPR compliance under a designated DPO.

Commercially, SVAS earns revenue primarily through one-time sales of medical devices to healthcare institutions via a direct sales force and acquired regional distributors; pricing is quote-based and not publicly disclosed. The company followed a deliberate capital-markets trajectory — Elite Project (2012), inaugural basket bond (2017), Euronext Growth Milan IPO (December 9, 2021) — and in March 2025 executed its first major international M&A, acquiring Belgrade-based medical device distributors Hermes Pharma and Megapharm for a combined EUR 7 million to expand Serbian market presence.

Name

SVAS Biosana

Legal name

SVAS BIOSANA S.p.A.

Website

https://svas.it

Company type

Public

Founded year

1972

Operating status

Operating

Headcount range

101–250 employees

Short description

Italian medical device manufacturer and distributor founded in 1972 and listed on Euronext Growth Milan. Produces incontinence aids, dialysis products, surgical instruments, advanced wound care, and cardiovascular devices across five sub-brands for hospitals, clinics, and home-care patients via ~400 employees.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Incontinence & Urological Supplies (Catheters, Briefs, Ostomy Supplies) (HSABAKAH)

akta.pro secondary industries

Adult Incontinence Products (CRADALAF), Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests) (CRADAMAK)

Keywords

• Medical devices manufacturing
• Pharmaceutical products
• Peritoneal dialysis supplies
• Surgical instruments
• Wound care dressings

Headquarters

HQ city

Naples

HQ country

Italy

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Devices Manufacturing and Distribution: Production and distribution of medical devices across multiple product lines including incontinence aids, dialysis products, surgical instruments, orthopedic devices, and advanced wound care products to healthcare providers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

SVAS Biosana plans, manufactures, and markets medical devices and pharmaceutical products across five business lines covering incontinence aids, peritoneal dialysis products, custom surgical packs and advanced wound dressings, cardiovascular implants and contrast agents, and cardiac/vascular surgery devices. The company operates three production sites in Italy and distributes medical devices to healthcare providers in Italy and international markets, supplemented by proprietary mobile applications (SVAS myDDT for courier management and SVAS myCare for patient delivery tracking).

Product overview

SVAS Biosana is a multi-brand medical device company comprising five product sub-brands — FARMEX (incontinence aids and personal care), SVAS (peritoneal dialysis and drug transfer devices), MEDICAL (custom surgical packs and advanced dressings), MARK MEDICAL (cardiovascular implants and contrast agents), and BORMIA (cardiac/vascular surgery and neuroradiology devices) — complemented by two digital mobile applications (SVAS myDDT for courier delivery management and SVAS myCare for patient delivery tracking), all integrated through the mySAD Web backend system. The company also operates two acquired Serbian distributors (Hermes Pharma and Megapharm) following its EUR 7 million acquisition in March 2025. SVAS Biosana listed on Euronext Growth Milan in December 2021 and operates 3 production sites in Italy with a workforce of approximately 400 employees across multiple countries.

Differentiator

Problem solved

Functional benefit

Brands

• FARMEX: Incontinence aids, medical treatments, cotton and personal care products
• SVAS
• MEDICAL
• MARK MEDICAL
• BORMIA

Products and services

• FARMEX

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• Hermes PharmacoreStrategic or Co-development Partner · 25 March 2025Serbian medical device distributor based in Belgrade, acquired by Svas Biosana for EUR 3.75 million. Part of strategic expansion in Serbian market.
• MegapharmcoreStrategic or Co-development Partner · 25 March 2025Serbian medical device distributor based in Belgrade, acquired by Svas Biosana for EUR 3.25 million. Part of strategic expansion in Serbian market.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• HARTMANN: German medical and hygiene products company with strong positions in wound care, incontinence management, and surgical supplies. Comparable to SVAS Biosana across multiple product lines and in European mid-tier medical device distribution.
• Diaverum: European renal care services and dialysis products provider operating across multiple countries. Comparable to SVAS Biosana's peritoneal dialysis offering and represents a potential cross-border partner or competitor in the European dialysis device market.
• Coloplast: Danish medical device company specializing in ostomy, continence, wound care, and skin health products. Directly comparable to SVAS Biosana's FARMEX incontinence and MEDICAL wound care lines, with overlapping chronic-care customer segments and similar European hospital distribution model.
• ConvaTec: UK-based medical products company focused on advanced wound care, ostomy, continence, and infusion care. Closely comparable to SVAS Biosana's FARMEX and MEDICAL sub-brands, particularly in incontinence and advanced wound dressings sold through hospital and home-care channels.

Broad incumbents

• Becton Dickinson: Global medical technology company with a broad portfolio of medical devices, surgical instruments, and injection systems. Comparable to SVAS Biosana in serving hospitals and healthcare providers with multi-category device offerings, though at substantially greater scale and with deeper international reach.
• Mölnlycke Health Care: Swedish medical device company specializing in wound care and surgical solutions. Comparable to SVAS Biosana's MEDICAL sub-brand (advanced wound dressings and surgical packs) and shares a similar European mid-market hospital sales motion.
• Smith & Nephew: Global medical technology company with portfolios in advanced wound management, orthopedics, and sports medicine. Comparable to SVAS Biosana's MARK MEDICAL orthopedic prosthesis line and MEDICAL wound care products, though operating at multinational scale.
• Medtronic: Global medical device leader with significant exposure to cardiovascular, cardiac surgery, and endovascular procedures. Comparable to SVAS Biosana's BORMIA (cardiac/vascular surgery, neuroradiology) and MARK MEDICAL (stents, heart valves) sub-brands, though operating at vastly greater scale and clinical evidence depth.
• Fresenius Medical Care: Global leader in dialysis products and services. Comparable to SVAS Biosana's SVAS sub-brand for peritoneal dialysis products, though at global scale with vertically integrated dialysis clinic operations.

Regional players

• Artsana Group: Italian consumer health and personal care company (parent of Chicco, Pic Solution, and Lycia). Comparable as an Italian-headquartered healthcare products company with personal care and medical device adjacencies overlapping with SVAS Biosana's FARMEX incontinence and personal care lines.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/pages/category/Medical-Service/SVAS-Biosana-SpA-1762463487352894
• LinkedInlinkedin.com/company/svas-biosana-srl

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries2 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SVAS Biosana